InMed Pharmaceuticals Inc
For the period ended Dec 31, 2024. Filed Feb 12, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Dec 31, 2024 · Filed Feb 12, 2025
INM$15.56+17.8%Stored close · as of Nov 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Unaudited Condensed Consolidated Financial Statements of
For the Three and Six Months Ended December 31, 2024 and 2023
(Expressed in U.S. Dollars)
December 31, 2024
| INDEX | Page | |
|---|---|---|
| Financial Statements (Unaudited) | ||
| ● | Condensed Consolidated Balance Sheets | 3 |
| ● | Condensed Consolidated Statements of Operations | 4 |
| ● | Condensed Consolidated Statements of Shareholders’ Equity | 5 |
| ● | Condensed Consolidated Statements of Cash Flows | 6 |
| ● | Notes to the Condensed Consolidated Financial Statements | 7-20 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.